The Use of the ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided With Lesions Smaller Than 15 mm
NCT01318473 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2012-10-03
Summary
This will be a prospective, single-arm, single-center, open-label study to evaluate the use of the ActiSight™ Needle Guidance System in patients with lung lesions smaller than 15 mm undergoing CT-guided percutaneous chest aspiration.
Target location will be in the chest area; the procedure will be performed by a trained physician.
Conditions
Interventions
- DEVICE
-
ActiSight™ Needle Guidance System
ActiSight™ Needle Guidance System is comprised of several sub-system components: a computer, a disposable ActiSensor optical sensor, and the disposable ActiSticker, which provides a reference for the insertion of the tool and for the camera.
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
collaborator OTHER_GOV -
ActiViews Ltd.
lead INDUSTRY
Principal Investigators
-
Boaz Tiran, Dr. · Tel-Aviv Sourasky Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
More Related Trials
-
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
NCT03737734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
NCT05802186 ·Status: RECRUITING ·Phase: NA
-
Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study
NCT07318402 ·Status: RECRUITING
-
Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
NCT05632913 ·Status: RECRUITING ·Phase: NA
-
A Phase 1 Study of [225Ac]-FPI-1434 Injection
NCT03746431 ·Status: TERMINATED ·Phase: PHASE1
-
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NCT04534127 ·Status: RECRUITING ·Phase: NA
-
4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients
NCT04717804 ·Status: COMPLETED ·Phase: NA
-
LungPoint ATV for Biopsy in Patients Undergoing Lobectomy
NCT02130115 ·Status: COMPLETED ·Phase: NA
-
Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy
NCT04310891 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
NCT04310020 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy
NCT01351116 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer
NCT00888823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
NCT05657743 ·Status: RECRUITING ·Phase: NA
-
Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
NCT04684186 ·Status: RECRUITING
-
4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition
NCT01018147 ·Status: COMPLETED ·Phase: NA
-
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial
NCT03077854 ·Status: UNKNOWN ·Phase: NA
-
On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software
NCT05666193 ·Status: COMPLETED ·Phase: NA
-
Computed Tomography (CT) in Head and Neck Patients
NCT00188656 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
NCT00471835 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
NCT03015883 ·Status: COMPLETED ·Phase: NA
-
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
NCT02795195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors
NCT07327515 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
NCT05451004 ·Status: RECRUITING ·Phase: PHASE3
-
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
NCT02743741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
NCT04375904 ·Status: RECRUITING ·Phase: PHASE2